Excessive Anxiety in the Postcoronary Patient

https://aihp.org/wp-content/uploads/2022/01/msdac-029.1a-librium.jpg
https://aihp.org/wp-content/uploads/2022/01/msdac-029.2a-librium.jpg
https://aihp.org/wp-content/uploads/2022/01/msdac-029.3a-librium.jpg

Title

Excessive Anxiety in the Postcoronary Patient

Description

Advertisement for Librium (chlordiazepoxide HCI), a medication manufactured by Roche Laboratories to reduce anxiety. The ad appeared in the journal Medical Economics on January 8, 1973. The ad recommends Librium for patients experiencing anxiety while recovering from a heart attack.

Creator

Publisher

Date

Rights

The advertisements in the AIHP Mickey Smith Drug Advertising Collection were published after 1923 and are not in the public domain. Under Fair Use, users may view or reproduce (print or download) materials from the collection for research, teaching, private study, or general interest. Users must provide proper attribution to the AIHP Mickey Smith Drug Advertising Collection in all copies. For any other uses, including reprinting or reproduction, users must contact the current rights holder for permission. For more information about the collection, please contact the American Institute of the History of Pharmacy: aihp@aihp.org.

Format

Language

eng

Identifier

msdac-029-librium

Extent

3 pages

Temporal Coverage

Original Format

Citation

Roche, “Excessive Anxiety in the Postcoronary Patient,” American Institute of the History of Pharmacy Digital Collection, accessed September 29, 2022, https://aihp.omeka.net/items/show/330.